Inogen authorises $30M buyback after issuing 2026 outlook
Inogen released its fourth-quarter and full-year 2025 financial results and issued preliminary revenue and profitability guidance for 2026. The company also authorised a $30 million share repurchase program to offset dilution and support its share price.
1. Inogen Announces 2025 Results and 2026 Outlook
Inogen reported its fourth-quarter and full-year 2025 financial results and issued preliminary revenue and adjusted EBITDA guidance for fiscal 2026, signaling continued growth expectations. Management highlighted operational milestones and expects to build on margins in the coming year.
2. $30 Million Share Repurchase Program
The company authorised a $30 million share repurchase program, granting Inogen flexibility to repurchase shares on the open market. This measure is intended to mitigate dilution from equity awards and demonstrate confidence in the company’s long-term prospects.